Alzeca Receives $11M for Early Alzheimer’s Detection Technology

15:57 EDT 17 Aug 2017 | Xconomy

Houston—Alzeca, which is developing an imaging agent to help doctors detect Alzheimer’s disease at its earliest stages, announced Thursday it has raised $11 million in a Series A round of funding. The Houston-based company has developed an imaging agent that it says can, when used with an MRI, detect the presence of abnormal brain proteins […]

Original Article: Alzeca Receives $11M for Early Alzheimer’s Detection Technology


More From BioPortfolio on "Alzeca Receives $11M for Early Alzheimer’s Detection Technology"

Quick Search


Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...